| This is beta-release v1.0 of the GtoImmuPdb. It contains the majority of features and functionality expected in the full public release. However, it remains under development and while it should not contain any critical bugs, some portions are not yet optimised and may lack full functionality or content. | Report a bug |
The IUPHAR Guide to IMMUNOPHARMACOLOGY ligand list
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
| Ligand name | ID | Synonyms | ||||
| A | Back to top | |||||
| 852A |
|
9025 | ||||
| A286982 |
|
6592 | A 286982, A-286982 | |||
| abatacept |
|
|
6891 | BMS-188667, CTLA4-IgG4m, Orencia®, RG-1046, RG-2077 | ||
| abediterol |
|
9326 | LAS-100977 | |||
| ABT-737 |
|
8320 | ABT 737, ABT737, compound 2 [PMID 17256834] | |||
| AC430 |
|
9177 | AC-430 | |||
| acalabrutinib |
|
8912 | ACP-196, Example 6 [US20140155385 A1] | |||
| ACT-389949 |
|
9511 | ||||
| ACTH {Sp: Human} |
|
|
3633 | Acthar®, adrenocorticotropic hormone (1-39), corticotropin | ||
| acumapimod |
|
9203 | BCT 197, BCT-197, BCT197, compound A [WO2013139809] | |||
| adalimumab |
|
|
4860 | D2E7, FKB327, Humira® | ||
| (-)-adrenaline |
|
|
479 | adrenalin, Auvi-Q®, Epipen®, l-adrenaline, L-epinephrine, levoepinephrine | ||
| AF12198 |
|
4861 | AF 12198, AF-12198 | |||
| AH6809 |
|
1896 | AH 6809, AH-6809 | |||
| AL-78898A |
|
9219 | 4(1MeW), POT-4 | |||
| alcaftadine |
|
|
7587 | Lastacaft®, R-89674 | ||
| alefacept |
|
|
6787 | Amevive®, BG 9273, BG 9712, BG-9273, BG-9712, Lfa3Tip | ||
| alemtuzumab |
|
|
6770 | campath 1H, Campath®, campath-1H, Lemtrada® | ||
| alimemazine |
|
|
7237 | Nedeltran®, trimeprazine | ||
| alpelisib |
|
7955 | BYL 719, BYL-719, NVP-BYL719 | |||
| 3 alpha-aminocholestane |
|
9564 | 3AC, 3 α-aminocholestane | |||
| alvelestat |
|
6476 | AZD 9668, AZD-9668, AZD9668, KB-105160 | |||
| amcinonide |
|
|
7060 | CL-34699, Cyclocort® | ||
| amelubant |
|
8463 | BIIL 284, BIIL-284 | |||
| AMG319 |
|
8917 | AMG 319, AMG-319 | |||
| AMG820 |
|
9106 | ||||
| amiselimod |
|
9319 | Example 1 [US20090137530], MT-1303, MT1303 | |||
| amiselimod phosphate |
|
9491 | amiselimod-P | |||
| amlexanox |
|
|
7113 | AA-673, Amlexanox®, Aphthasol®, CHX-3673 | ||
| anakinra |
|
|
6972 | antril, Kineret® | ||
| ancriviroc |
|
804 | SCH 351125, SCH-351125, SCH-C | |||
| andecaliximab |
|
9510 | GS-5745 | |||
| anifrolumab |
|
8258 | MDX-1333, MEDI-546 | |||
| apafant |
|
1860 | WEB 2086 BS, WEB-2086 | |||
| apremilast |
|
|
7372 | CC-10004, Otezla® | ||
| APRIL {Sp: Human} |
|
5068 | A proliferation-inducing ligand, TALL2, TNF- and APOL-related leukocyte expressed ligand 2, TNF-related death ligand 1, TRDL-1, ZTNF2 | |||
| arformoterol |
|
|
7479 | Brovana®, YM-08316 | ||
| (R)-ARN2508 |
|
9000 | compound (-)-10r [PMID: 26774927], example 19 [WO2014023643] | |||
| (S)-ARN2508 |
|
8999 | compound (+)-10r [PMID: 26774927], example 20 [WO2014023643] | |||
| ARRY-382 |
|
9108 | ARRY 382, ARRY382 | |||
| AS101 |
|
437 | AS 101, AS-101 | |||
| asimadoline |
|
9279 | EMD 61 753, EMD 61753, EMD-61753 | |||
| ASP4058 |
|
9569 | ASP-4058 | |||
| aspirin |
|
|
4139 | Acetophen®, acetylsalicylic acid, Aspirin® | ||
| AT38 |
|
9020 | [3-(aminocarbonyl)furoxan-4-yl]methyl salicylate | |||
| atacicept |
|
9517 | TACI-Fc, TACI-Ig | |||
| ATB-346 |
|
9534 | ATB 346 | |||
| atezolizumab |
|
|
7990 | MPDL3280A, Tecentriq® | ||
| atracurium |
|
|
9537 | atracurium besilate, atracurium dibesylate, BW 33A, Tracrium® | ||
| auranofin |
|
|
6306 | Ridaura®, SK&F-39162, SK-39162 | ||
| avacopan |
|
9450 | CCX-168, CCX168 | |||
| avelumab |
|
|
8735 | Bavencio®, MSB-0010718C, MSB0010718C | ||
| AZ13102909 |
|
9577 | AZ909 | |||
| AZ3451 |
|
9560 | ||||
| azacitidine |
|
|
6796 | 5-AZAC, 5-azacytidine, ladakamycin, U-18496, Vidaza® | ||
| azapro-3 |
|
9221 | ||||
| azatadine |
|
|
7119 | Optimine®, SCH-10649 | ||
| azathioprine |
|
|
7120 | Azasan®, BW-57-322, Imuran® | ||
| AZD1236 |
|
7844 | AZD 1236, AZD-1236 | |||
| AZD1981 |
|
7680 | AZD 1981, AZD-1981 | |||
| AZD2423 |
|
7825 | AZD 2423, AZD-2423 | |||
| AZD5069 |
|
8948 | ||||
| AZD5672 |
|
7686 | AZD 5672, AZD-5672 | |||
| AZD6605 |
|
7823 | AZ 11920155, AZ-11920155, AZ11920155, AZD 6605, AZD-6605 | |||
| AZD6703 |
|
7687 | AZ 12012199, AZ-12012199, AZ12012199, AZD 6703, AZD-6703 | |||
| AZD7594 |
|
9325 | AZ13189620 | |||
| AZD7986 |
|
9412 | compound 30 | |||
| AZD8848 |
|
9256 | DSP-3025 | |||
| AZD9056 |
|
7826 | AZD 9056, AZD-9056 | |||
| azelaic acid |
|
|
7484 | Azelex®, Finacea®, ZK-62498 | ||
| AZ11657312 (salt free) |
|
7722 | ||||
| B | Back to top | |||||
| bafetinib |
|
7906 | INNO-406, Lyn-IN-1, NS-187 | |||
| BAFF {Sp: Human} |
|
5069 | B cell-activating factor, CD257 antigen, dendritic cell-derived TNF-like molecule | |||
| baricitinib |
|
7792 | INCB-028050, LY-3009104, LY3009104 | |||
| basiliximab |
|
|
6879 | CHI-621, L04AC02, SDZ-CHI-621, Simulect® | ||
| BAYu9773 |
|
3381 | BAY u9773, BAY-u 9773 | |||
| beclometasone |
|
|
7059 | beclomethasone, SCH-18020W | ||
| beclometasone dipropionate |
|
|
5894 | beclomethasone dipropionate, Beconase®, Qnasl®, Vancenase® | ||
| belatacept |
|
|
6892 | BMS-224818, LEA29Y, Nulojix® | ||
| belimumab |
|
|
6887 | Benlysta®, hBlySmAb-1.1, lymphostat-B | ||
| belnacasan |
|
9035 | VX-765 | |||
| benralizumab |
|
7674 | BIW-8405, KHK4563, MEDI-563 | |||
| 3beta-Hydroxy-20(29)-lupene |
|
9028 | Fagarasterol, Lupeol | |||
| betamethasone |
|
|
7061 | SCH-4831 | ||
| BI605906 |
|
9357 | 3-Amino-4-(1,1-difluoro- propyl)-6-(4-methanesulfonyl- piperidin-1-yl)-thieno[2,3- b]pyridine-2-carboxylic acid amide, compound 115 [US20070293533] | |||
| bihelical apoA-I mimetic peptide 5A |
|
9183 | 5A peptide | |||
| BIIB021 |
|
9258 | ||||
| bimekizumab |
|
9411 | CA028_0496, CDP4940, gL7gH9, UCB-4940, UCB4940, Zu-G1 | |||
| bimosiamose |
|
9049 | compound 15e [PMID: 9544210], TBC 1269, TBC-1269, TBC1269 | |||
| BIX02189 |
|
9380 | BIX 02189, BIX-02189 | |||
| blinatumomab |
|
|
7384 | Blincyto®, bscCD19xCD3, MEDI-538, MT-103, MT103 | ||
| blisibimod |
|
9518 | A-623, AGP3 peptibody, AMG 623, Fc-Agp-3 | |||
| BMS-345541 |
|
5669 | BMS 345541, BMS345541 | |||
| BMS-561392 |
|
6509 | BMS 561392, BMS561392, DPC-333 | |||
| BMS-582949 |
|
7838 | BMS 582949, BMS582949, PS 540446, PS-540446, PS540446 | |||
| BMS-681 |
|
9430 | compound 13d [PMID: 25893046] | |||
| BMS-817399 |
|
9497 | compound 29 [PMID: 25101488] | |||
| BMS-986016 |
|
9536 | ||||
| bosutinib |
|
|
5710 | Bosulif®, SK 606, SK-606, SKI 606 | ||
| brazikumab |
|
9293 | AMG 139, AMG-139, MEDI2070 | |||
| brentuximab vedotin |
|
|
6772 | Adcetris®, anti-CD30 ADC SGN-35, SGN 35 | ||
| briakinumab |
|
9213 | ABT-874, J-695, J695, Ozespa | |||
| brimapitide |
|
9101 | AM-111, D-JNKI-1, XG-102 | |||
| BRL-15572 |
|
10 | BRL 15572, BRL-15,572, BRL15572 | |||
| brodalumab |
|
|
7540 | AMG-827, AMG827, Lumicef®, Siliq® | ||
| bromfenac |
|
|
7131 | AHR-10282B, Bromday®, Prolensa®, Xibrom® | ||
| budesonide |
|
|
7434 | Entocort®, Pulmicort®, S-1320, Uceris® | ||
| BX 471 |
|
767 | BX-471, BX-741 | |||
| BX-795 |
|
8006 | BX 795, BX795 | |||
| C | Back to top | |||||
| C108297 |
|
9180 | Compound 52 [PMID:18226897] | |||
| C391 |
|
9570 | compound 5 [PMID: 27994760] | |||
| C5a {Sp: Human} |
|
573 | C5a anaphylatoxin, complement component C5a, human complement protein | |||
| cabiralizumab |
|
9107 | FPA-008, FPA008 | |||
| canakinumab |
|
|
6773 | ACZ 885, ACZ885, Ilaris® | ||
| carbenoxolone |
|
4151 | ||||
| carprofen |
|
|
7141 | Ro-205720000 | ||
| CCL1 {Sp: Human} |
|
812 | I309, TCA-3 | |||
| CCL11 {Sp: Human} |
|
769 | eotaxin | |||
| CCL13 {Sp: Human} |
|
770 | monocyte chemotactic protein-4 | |||
| CCL14 {Sp: Human} |
|
753 | CCL14a, CKβ1, haemofiltrate CC chemokine 1 (HCC-1), HCC-1(1-74) | |||
| CCL15 {Sp: Human} |
|
754 | Lkn-1 [Leukotactin-1], macrophage inflammatory protein-1δ, MIP-1δ | |||
| CCL16 {Sp: Human} |
|
1272 | ||||
| CCL17 {Sp: Human} |
|
797 | TARC, thymus- and activation-regulated chemokine | |||
| CCL18 {Sp: Human} |
|
4382 | macrophage inflammatory protein 4, small-inducible cytokine A18 | |||
| CCL19 {Sp: Human} |
|
810 | β-chemokine exodus-3, ck β-11, ckβ11, MIP-3β | |||
| CCL2 {Sp: Human} |
|
771 | ||||
| CCL20 {Sp: Human} |
|
808 | LARC, liver and activation-regulated chemokine, macrophage inflammatory protein-3α, MIP-3α | |||
| CCL21 {Sp: Human} |
|
811 | ckβ9, TCA-4 | |||
| CCL22 {Sp: Human} |
|
798 | dc/β-ck, macrophage-derived chemokine, STCP1 | |||
| CCL23 {Sp: Human} |
|
755 | ckβ8-1, myeloid progenitor inhibitor factor-1 | |||
| CCL24 {Sp: Human} |
|
775 | eotaxin-2 | |||
| CCL25 {Sp: Human} |
|
817 | ||||
| CCL26 {Sp: Human} |
|
776 | MIP-4α, PTEC | |||
| CCL27 {Sp: Human} |
|
3646 | ||||
| CCL28 {Sp: Human} |
|
3649 | ||||
| CCL3 {Sp: Human} |
|
756 | macrophage inflammatory protein-1α, MIP-1α | |||
| CCL4 {Sp: Human} |
|
757 | HC21, macrophage inflammatory protein-1β, MIP-1β | |||
| CCL5 {Sp: Human} |
|
758 | eosinophil chemotactic cytokine [EoCP], regulated upon activation normal T cell expressed and secreted (RANTES) | |||
| CCL7 {Sp: Human} |
|
759 | ||||
| CCL8 {Sp: Human} |
|
772 | monocyte chemotactic protein-2 | |||
| CCL1 {Sp: Mouse} |
|
4404 | ||||
| CCL11 {Sp: Mouse} |
|
787 | murine eotaxin | |||
| CCL12 {Sp: Mouse} |
|
4435 | ||||
| CCL19 {Sp: Mouse} |
|
4417 | ||||
| CCL2 {Sp: Mouse} |
|
4406 | ||||
| CCL20 {Sp: Mouse} |
|
4418 | ||||
| CCL22 {Sp: Mouse} |
|
4420 | ||||
| CCL24 {Sp: Mouse} |
|
4421 | ||||
| CCL25 {Sp: Mouse} |
|
4422 | ||||
| CCL27 {Sp: Mouse} |
|
4462 | ||||
| CCL28 {Sp: Mouse} |
|
4463 | ||||
| CCL3 {Sp: Mouse} |
|
4408 | ||||
| CCL4 {Sp: Mouse} |
|
4410 | ||||
| CCL7 {Sp: Mouse} |
|
4413 | ||||
| CCL8 {Sp: Mouse} |
|
4415 | ||||
| CCL9 {Sp: Mouse} |
|
4434 | ||||
| CCL5 {Sp: Mouse, Rat} |
|
4412 | ||||
| CCL11 {Sp: Rat} |
|
4416 | ||||
| CCL2 {Sp: Rat} |
|
4407 | ||||
| CCL20 {Sp: Rat} |
|
4419 | ||||
| CCL3 {Sp: Rat} |
|
4409 | ||||
| CCL4 {Sp: Rat} |
|
4411 | ||||
| CCL7 {Sp: Rat} |
|
4414 | ||||
| Ccl21a {Sp: Mouse} |
|
8651 | 6Ckine-Ser, Exodus-2 | |||
| Ccl21b {Sp: Mouse} |
|
8652 | 6Ckine-Leu, Exodus-2 | |||
| CCR2-RA-[R] |
|
9431 | analog 49 (Dasse et al., 2007) | |||
| CDP840 |
|
9330 | CDP 840, CDP-840 | |||
| celecoxib |
|
|
2892 | Celecox®, Onsenal® | ||
| cerdulatinib |
|
8957 | PRT 062070, PRT-062070, PRT-2070, PRT062070 | |||
| certolizumab pegol |
|
|
6774 | CDP870, Cimzia®, PHA 738144 | ||
| cetirizine |
|
|
1222 | Reactine®, Zyrtec® | ||
| CGI1746 |
|
8066 | CGI 1746, CGI-1746 | |||
| CGI560 |
|
9264 | CGI-560 | |||
| CHMFL-BTK-11 |
|
9516 | ||||
| cicaprost |
|
1917 | ZK 96480, ZK-96480 | |||
| ciclesonide |
|
|
7469 | Alvesco®, Omnaris®, RPR-251526 | ||
| cilomilast |
|
7407 | SB-207499 | |||
| cipemastat |
|
6466 | Ro 28-2653 | |||
| clazakizumab |
|
9195 | ALD-518, ALD518, BMS-945429 | |||
| clemastine |
|
|
6063 | HS-592, meclastin, Tavegil®, Tavist® | ||
| clobenpropit |
|
1223 | VUF 9153, VUF-9153 | |||
| clobetasol propionate |
|
|
7062 | CCI-4725, Clobex®, Dermovate®, GR 2/925, Temovate® | ||
| clobetasone |
|
|
9088 | Eumovate® | ||
| clofazimine |
|
|
9184 | Lamprene® | ||
| CNX-774 |
|
9266 | ||||
| complement C3 {Sp: Human} |
|
9414 | ||||
| complement C5 {Sp: Human} |
|
8712 | ||||
| compound 48/80 |
|
5531 | ||||
| compound 4g [PMID: 22220592] |
|
9236 | Example XCII [US20160175314] | |||
| compound 8ic [PMID: 19081254] |
|
9478 | CCR4 Antagonist | |||
| compound II [PMID: 21329883] |
|
9579 | ||||
| compound 5i [PMID: 24099220] |
|
8223 | GNF-PF-3777 | |||
| compound 12 [PMID: 27448772] |
|
9453 | ||||
| compound 14 [PMID: 19136975] |
|
8781 | FIPI | |||
| compound 15 [PMID: 25411721] |
|
9078 | example 252 [WO2007110237] | |||
| compound 16 [PMID: 26794040] |
|
9223 | ||||
| compound 1 [PMID: 24930776] |
|
9092 | DB36 | |||
| compound 21 [PMID: 22802221] |
|
6918 | C21 | |||
| compound 21 [PMID: 24900635] |
|
8187 | ||||
| compound 24 [PMID: 26987013 ] |
|
9252 | ||||
| compound 36 [PMID: 21958547] |
|
9391 | ||||
| compound 3 [PMID: 14640538] |
|
8675 | 2-mercaptomethyl-3-guanidinoethylthiopropanoic acid, 2-Mmgetpa, DL-2-mercaptomethyl-3-guanidinoethyl-thiopropanoic acid, mergepta, MGTA | |||
| compound 41 [PMID: 25000588] |
|
9349 | ||||
| compound 43 [PMID: 26751273] |
|
9492 | ||||
| compound 6 [PMID: 25874594] |
|
9178 | ||||
| compound 1 [WO2012007375] |
|
8084 | ||||
| compound 7 [WO2012007375] |
|
8085 | ||||
| compstatin |
|
9218 | ||||
| CORM-2 |
|
9535 | ||||
| corticosterone |
|
2869 | ||||
| corticotropin zinc hydroxide |
|
|
6967 | |||
| cortisol |
|
|
2868 | Acticort®, Plenadren® | ||
| 18c [PMID: 25901531] |
|
9227 | ||||
| crenolanib |
|
7882 | ARO-002, CP 868596, CP-868596 | |||
| crisaborole |
|
|
9151 | AN 2728, AN2728, compound 5b [PMID: 19303290], Eucrisa® | ||
| cromoglicic acid |
|
|
7608 | cromoglycate, cromolyn, cromolyn sodium, FPL-670, Intal®, Opticrom®, sodium cromoglicate | ||
| CUDC-907 |
|
8952 | CUDC 907, PI3K/HDAC Inhibitor centn | |||
| CXCL1 {Sp: Human} |
|
819 | GROα, melanocyte growth-stimulatory activity, MIP-2 | |||
| CXCL10 {Sp: Human} |
|
835 | ||||
| CXCL11 {Sp: Human} |
|
836 | IP9, ITAC | |||
| CXCL12β {Sp: Human} |
|
845 | SDF-1β, stromal cell-derived factor-1 (SDF-1), stromal cell-derived factor-1β | |||
| CXCL12δ {Sp: Human} |
|
8531 | ||||
| CXCL12ε {Sp: Human} |
|
8532 | ||||
| CXCL12γ {Sp: Human} |
|
8530 | ||||
| CXCL12φ {Sp: Human} |
|
8533 | ||||
| CXCL13 {Sp: Human} |
|
3645 | BCA-1 | |||
| CXCL16 {Sp: Human} |
|
855 | ||||
| CXCL17 {Sp: Human} |
|
6479 | C-X-C motif chemokine 17, dendritic cell and monocyte chemokine-like protein | |||
| CXCL2 {Sp: Human} |
|
827 | GROβ, MIP-2α | |||
| CXCL3 {Sp: Human} |
|
828 | GROγ, MIP-2β | |||
| CXCL4 {Sp: Human} |
|
3685 | platelet factor 4 (PF4) | |||
| CXCL5 {Sp: Human} |
|
829 | ENA-78 | |||
| CXCL6 {Sp: Human} |
|
820 | ||||
| CXCL7 {Sp: Human} |
|
830 | PPBP | |||
| CXCL8 {Sp: Human} |
|
821 | interleukin-8 | |||
| CXCL9 {Sp: Human} |
|
837 | MIG, monokine induced by gamma-interferon | |||
| CX3CL1 {Sp: Human} |
|
856 | fractalkine, neurotactin | |||
| CXCL1 {Sp: Mouse} |
|
4423 | ||||
| CXCL10 {Sp: Mouse} |
|
4430 | ||||
| CXCL11 {Sp: Mouse} |
|
4432 | ||||
| CXCL12 {Sp: Mouse} |
|
4465 | ||||
| CXCL13 {Sp: Mouse} |
|
4466 | ||||
| CXCL16 {Sp: Mouse} |
|
4433 | ||||
| CXCL2 {Sp: Mouse} |
|
4424 | macrophage inflammatory protein 2 (MIP-2) | |||
| CXCL3 {Sp: Mouse} |
|
4426 | ||||
| CXCL5 {Sp: Mouse} |
|
4428 | ||||
| CXCL9 {Sp: Mouse} |
|
4429 | ||||
| CX3CL1 {Sp: Mouse} |
|
4468 | ||||
| CXCL1 {Sp: Rat} |
|
826 | CINC, GROα, macrophage inflammatory protein-2 | |||
| CXCL10 {Sp: Rat} |
|
4431 | ||||
| CXCL16 {Sp: Rat} |
|
4467 | ||||
| CXCL2 {Sp: Rat} |
|
4425 | ||||
| CXCL3 {Sp: Rat} |
|
4427 | ||||
| CXCL5 {Sp: Rat} |
|
4464 | ||||
| CX3CL1 {Sp: Rat} |
|
4469 | ||||
| cyclosporin A |
|
|
1024 | ciclosporin, cyclosporine, cyclosporine A, Neoral®, Sandimmune® | ||
| D | Back to top | |||||
| D4476 |
|
5940 | casein kinase I inhibitor, CK1 inhibitor, D 4476 | |||
| daclizumab |
|
|
6880 | L04AC01, RO-24-7375, Ro-247375, Zenapax® | ||
| danirixin |
|
8500 | GSK-1325756B, GSK1325756, GSK1325756B | |||
| daratumumab |
|
|
7395 | 3003-005, Darzalex®, HuMax-CD38, JNJ-54767414 | ||
| dasatinib |
|
|
5678 | BMS 345825, BMS 354825, BMS 35482513, Sprycel® | ||
| decernotinib |
|
8309 | adelatinib, VRT-831509, VX-509 | |||
| dectrekumab |
|
8714 | QAX-576, QAX576 | |||
| deflazacort |
|
|
9477 | Emflaza®, MDL 458 | ||
| defoslimod |
|
9024 | OM 174, OM-174 | |||
| denileukin diftitox |
|
|
7044 | DAB389 IL2, LY 335348, Ontak® | ||
| desloratadine |
|
|
7157 | Clarinex®, SCH-34117 | ||
| desonide |
|
|
7066 | D-2083, Desowen® | ||
| desoximetasone |
|
|
7067 | A-41-304, HOE-304, R-2113, Topicort® | ||
| dexamethasone |
|
|
2768 | Decadron®, desametasone, fluormethylprednisolone | ||
| diclofenac |
|
|
2714 | Cataflam®, CGP-45840B, GP-45840, Voltaren®, Voltarol® | ||
| difelikefalin |
|
9044 | CR845, D-Phe-D-Phe-D-Leu-D-Lys-[γ-(4-N-piperidinyl)amino carboxylic acid], FE-202845, SEQ ID NO: 2 | |||
| diflorasone diacetate |
|
|
7068 | Psorcon®, U-34865 | ||
| diflunisal |
|
|
7162 | Dolobid® | ||
| difluprednate |
|
|
7474 | DFBA, Durezol®, W-6309 | ||
| dilmapimod |
|
7815 | SB-681323 | |||
| dinaciclib |
|
7379 | SCH727965 | |||
| diphenylpyraline |
|
|
7165 | |||